Veteran medical imaging diagnostic professional Randy Hill appointed to Myocardial Solutions board

Myocardial Solutions, an MRI technologies maker, has appointed Randy Hill to its board of directors, the company said in a statement.

Hill was formerly CEO of Siemens Healthcare and VasoDiagnostics, where he will remain a director.

"I am very impressed with MSI's innovative SENC technology and its capability to invigorate the potential of CMR by providing, almost real time, quantitative cardiac stress testing results to enable physician decision-making,” Hill said. “Myocardial's strain testing technology is well validated, fast, easy to use and accurate. Thus, it should offer a very competitive alternative to cardiac nuclear stress testing.”

Prior to VasoDiagnostics, he was the chairman of the Medical Imaging and Technology Alliance, an industry association that represents more than 90 percent of medical imaging technology companies.

"Randy's extensive experience in the medical imaging diagnostic industry, as well as his background in sales and marketing, uniquely qualifies him to help MSI strategically position its cardiac magnetic resonance (CMR) technology for cardiac stress testing," said John Funkhouser, CEO of Myocardial Solutions. "It's a great honor to welcome Randy, a well-respected industry leader, to our board and be able to call on his deep industry knowledge and experience."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.